/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Aziz Ouerdani

Johnson & Johnson (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

13

Papers

111

Citations

6

h-index

4

i10-index

Aziz Ouerdani is an academic researcher from Johnson & Johnson (United States). The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Mathematical Biology Tumor Growth & Pancreatic and Hepatic Oncology Research. The author has an h-index of 6, co-authored 12 publications.

Research Topics

Chronic Lymphocytic Leukemia Research Mathematical Biology Tumor Growth Pancreatic and Hepatic Oncology Research Lung Cancer Treatments and Mutations Angiogenesis and VEGF in Cancer

Papers by this author

works

Evaluation of Bruton’s Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL)

2025 · Cancer Chemotherapy and Pharmacology · 6 citations

https://doi.org/10.1007/s00280-025-04753-0

Aziz Ouerdani Belén Valenzuela Nicoline Treijtel Nahor Haddish‐Berhane

Research topics

topics

Chronic Lymphocytic Leukemia Research

Mathematical Biology Tumor Growth

Pancreatic and Hepatic Oncology Research

Lung Cancer Treatments and Mutations

Angiogenesis and VEGF in Cancer

Chat about Author

Papers

Chat

Click to start Chat